GSK to buy US cancer treatment firm Nuvalent for $10.6bn ⊖⊖
found
a story from The Guardian ⚠️ › International
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
since
auto-detected in 26 stories
20 hours ago
found
a story from The Guardian ⚠️ › International
British drugmaker’s new chief executive Luke Miels announces one of its biggest deals
Business live – latest updates
GSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, a…
41 days ago
47 days ago
HMRC owed more than £640,00 by company that advised clients such as TikTok, GSK and Palantir
Peter Mandelson’s former consultancy business, Global Counsel, went bust owing £4.6m – including more than …
58 days ago
found
a story from The Guardian ⚠️ › International
Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug
GSK has revealed positive results for a treatment for gynaecological cancers as its chief executiv…
3 months ago
4 months ago
New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential
It’s a miracle. A mere 25 years after Glaxo Wellcome and SmithKline Beecham merg…
5 months ago
found
a story from The Guardian ⚠️ › International
Emma Walmsley’s praise for US pharmaceutical market piles pressure on the UK government
Business live – live updates
The chief executive of GSK yesterday declared the US to be the best place for pharma…
8 months ago